Benzinga - Gainers
- Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
- OncoSec Medical Incorporated (NASDAQ: ONCS) rose 75.9% to $1.90 in pre-market trading after the company requests withdrawal of registration statement, The company said it has opted not to pursue offering thereby at this time.
- Lionheart III Corp (NASDAQ: LION) shares rose 56.2% to $22.80 in pre-market trading after jumping around 98% on Tuesday.
- China Pharma Holdings Inc (NASDAQ: CPHI) rose 20.8% to $0.081 in pre-market trading. China Pharma recently announced a 1-for-10 reverse stock split.
- Helbiz Inc (NASDAQ: HLBZ) rose 19.1% to $0.17 in pre-market trading after gaining over 21% on Tuesday.
- Sarepta Therapeutics Inc (NASDAQ: SRPT) rose 17% to $142.90 in pre-market trading after the company reported better-than-expected Q4 results.
- Landos Biopharma Inc (NASDAQ: LABP) shares rose 14.9% to $0.43 in pre-market trading. Landos Biopharma announced transfer of LANCL portfolio, including Omilancor, LABP-104 and LABP-111 to Landos' founder.
- China SXT Pharmaceuticals Inc (NASDAQ: SXTC) rose 14.7% to $0.45 in pre-market trading after gaining over 3% on Tuesday.
- Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) rose 9.7% to $29.30 in pre-market trading. Cerevel Therapeutics recently posted a narrower-than-expected quarterly loss.
- Bilibili Inc - ADR (NASDAQ: BILI) shares rose 8.8% to $21.00 in pre-market trading after dropping over 3% on Tuesday.
- OKYO Pharma (NASDAQ: OKYO) fell 24.2% to $1.69 in pre-market. US Customs cleared OKYO Pharma's GMP packaged OK-101 drug for Phase 2 clinical trial for treating dry eye disease.
- Novavax Inc (NASDAQ: NVAX) fell 24% to $7.04 in pre-market trading after the company reported worse-than-expected Q4 results and said substantial doubt exists regarding its ability to continue as a going concern.
- Marqeta Inc (NASDAQ: MQ) fell 19.1% to $4.69 in pre-market trading after the company reported fourth-quarter results and issued guidance for slowing growth.
- Beamr Imaging Ltd. (NASDAQ: BMR) shares fell 18.6% to $2.97 in pre-market trading. Beamr Imaging priced its initial public offering of 1,950,000 at a public offering price of $4.00 per share.
- Obseva SA (NASDAQ: OBSV) shares dropped 15.2% to $0.12 in pre-market trading after jumping 43% on Tuesday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
- Brightspire Capital Inc (NYSE: BRSP) fell 14.4% to $6.32 in pre-market trading after the company announced an offering of 30,358,213 shares by DigitalBridge Group, Inc.
- Performance Shipping Inc (NASDAQ: PSHG) fell 13% to $2.34 in pre-market trading. Performance Shipping announced termination of at-the-market offering.
- Grove Collaborative Holdings Inc (NYSE: GROV) fell 12.7% to $0.38 in pre-market trading.
- Catalyst Biosciences Inc (NASDAQ: CBIO) fell 11.4% to $0.26 in pre-market trading. Catalyst Biosciences shares jumped around 24% on Tuesday after GC Biopharma signed an Asset Purchase Agreement with the company.
- AMC Entertainment Holdings Inc (NYSE: AMC) shares fell 8.5% to $6.53 in pre-market trading after the company posted Q4 results. The company ended the quarter with available liquidity of $842.7 million and debt of $4.95 billion.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.